It may not be surprising to many when a trendy technology buzzword goes practically viral. This is what happened with artificial intelligence (AI). It started in the late nineteen-nineties and took a spin in the twenty-first century. The gaining momentum and the ever-growing advancement in artificial intelligence have left every company, marketing sector, and the financial firms spell-bounded. New trends of AI are on the rise. The research from Gartner showed that by 2020, 85% of the customer interactions are going to be managed without human interference.
In any industry, the term "marketing” is always a key factor in determining the success of a business. In the pharmaceutical industry, whether the business is being done directly to the customer or to the physician, a lot of data must be kept for executing successful campaigns. While data is important, the last thing companies want to do is market their brand to people who want nothing to do with them. So, the question becomes, how do you know who’s interested?
Today, more people have access to the internet what it was a decade ago and the number is going to increase rapidly due to the advancement of digital transformation. A report by Statista shows that the number of internet users worldwide was 3.58 billion in 2017, up from 3.39 billion in the previous year.
Whether you’re knowledgeable on Clinical Trials and the process that goes into it or not, it is correctly assumed that the work is far from light. There are four phases for each study conducted that tells the plot of the story, but doesn’t dive into the supporting elements within.
Expiring patterns and growing pressure from authorities to reduce drug prices are testing pharma industry. Digital transformation is the avenue which will help companies succeed in mitigating these challenges. Digital transformation provides keys to unlocking the patient access and interaction challenges. Prescribers are finding various avenues to find the information which in turn is reducing the face time reps get with the prescribers.
Swapan Kumar Manna | July 19, 2017
Anupam Nandwana | January 5, 2018
Anupam Nandwana | February 8, 2017
Swapan Kumar Manna | December 19, 2017
Avirup Basu | June 7, 2018